Drug Shortage Report for APO-LEVETIRACETAM

Last updated on 2018-03-15 History
Report ID 17251
Drug Identification Number 02285932
Brand name APO-LEVETIRACETAM
Common or Proper name LEVETIRACETAM
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) LEVETIRACETAM
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-12-22
Actual start date 2017-12-18
Estimated end date 2018-04-06
Actual end date 2018-03-14
Shortage status Resolved
Updated date 2018-03-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2018-03-15 French Compare
v20 2018-03-15 English Compare
v19 2018-01-16 French Compare
v18 2018-01-16 English Compare
v17 2017-12-20 French Compare
v16 2017-12-20 English Compare
v15 2017-12-15 French Compare
v14 2017-12-15 English Compare
v13 2017-10-31 French Compare
v12 2017-10-31 English Compare
v11 2017-10-24 French Compare
v10 2017-10-24 English Compare
v9 2017-10-10 French Compare
v8 2017-10-10 English Compare
v7 2017-08-22 French Compare
v6 2017-08-22 English Compare
v5 2017-08-22 English Compare
v4 2017-08-21 French Compare
v3 2017-08-21 English Compare
v2 2017-07-26 French Compare

Showing 1 to 20 of 21